- Broxaldine
-
- $74.00 / 25mg
-
2026-01-22
- CAS:3684-46-6
- Min. Order:
- Purity: 100.00%
- Supply Ability: 10g
- broxaldine
-
- $1.00 / 1KG
-
2019-12-31
- CAS:3684-46-6
- Min. Order: 1KG
- Purity: 95-99%
- Supply Ability: 1ton
|
| | broxaldine Basic information |
| Product Name: | broxaldine | | Synonyms: | 5,7-Dibromo-2-methylquinoline-8-ol benzoate;5,7-Dibromo-8-benzoyloxy-2-methylquinoline;Brobenzoxaldine;5,7-Bibromo-2-methylquinolin-8-ol;Aids112123;Aids-112123;broxaldine;Broxaldine (Brobenzoxaldine) | | CAS: | 3684-46-6 | | MF: | C17H11Br2NO2 | | MW: | 421.08 | | EINECS: | 222-971-1 | | Product Categories: | | | Mol File: | 3684-46-6.mol |  |
| | broxaldine Chemical Properties |
| Boiling point | 538.1±50.0 °C(Predicted) | | density | 1.692±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 5 mg/ml; DMF:PBS (pH 7.2) (1:2): 0.3 mg/ml; DMSO: 1 mg/ml | | form | A solid | | pka | 0.73±0.50(Predicted) | | color | White to off-white |
| RIDADR | 3249 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | broxaldine Usage And Synthesis |
| Uses | Broxaldine (Brobenzoxaldine) is an antiprotozoal agent. Broxaldine inhibits Clostridium difficile with a MIC value of 4 μM, and has antifungal effects[1][2]. | | References | [1] Hazra SK, et al. Therapeutic trial of a combination of broxyquinoline and brobenzoxaldine in the treatment of leprosy. Lepr India. 1979 Oct;51(4):505-10. PMID:118304
[2] AbdelKhalek A, et al. Screening for potent and selective anticlostridial leads among FDA-approved drugs. J Antibiot (Tokyo). 2020 Mar 4. DOI:10.1038/s41429-020-0288-3 |
| | broxaldine Preparation Products And Raw materials |
|